Novel Treatments for PXE: Targeting the Systemic and Local Drivers of Ectopic Calcification
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242015041 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ida Joely Jacobs und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences MS Program, Jefferson College of Life Sciences, Thomas Jefferson University, Philadelphia, PA 19107, USA. Hauptthemen laut MEDLINE: Pseudoxanthoma Elasticum, Calcinosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, PXE International.
Abstract (Originalsprache)
Pseudoxanthoma elasticum (PXE) is a heritable multisystem ectopic calcification disorder. The gene responsible for PXE, ABCC6, encodes ABCC6, a hepatic efflux transporter regulating extracellular inorganic pyrophosphate (PPi), a potent endogenous calcification inhibitor. Recent studies demonstrated that in addition to the deficiency of plasma PPi, the activated DDR/PARP signaling in calcified tissues provides an additional possible mechanism of ectopic calcification in PXE. This study examined the effects of etidronate (ETD), a stable PPi analog, and its combination with minocycline (Mino), a potent inhibitor of DDR/PARP, on ectopic calcification in an Abcc6-/- mouse model of PXE. Abcc6-/- mice, at 4 weeks of age, before the development of ectopic calcification, were treated with ETD, Mino, or both for 18 weeks. Micro-computed tomography, histopathologic examination, and quantification of the calcium content in Abcc6-/- mice treated with both ETD and Mino revealed further reduced calcification than either treatment alone. The effects were associated with reduced serum alkaline phosphatase activity without changes in plasma PPi concentrations. These results suggest that ETD and Mino combination therapy might provide an effective therapeutic approach for PXE, a currently intractable disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Sciences MS Program, Jefferson College of Life Sciences, Thomas Jefferson University, Philadelphia, PA 19107, USA.
- Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
- PXE International Center of Excellence in Research and Clinical Care, Thomas Jefferson University, Philadelphia, PA 19107, USA.
ORCID-Profile: Qiaoli Li
Förderung
- NIAMS NIH HHS
- NIH HHS
- PXE International
- National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Jacobs, I. J., & Li, Q. (2023). Novel Treatments for PXE: Targeting the Systemic and Local Drivers of Ectopic Calcification. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015041
Vancouver
Jacobs IJ, Li Q. Novel Treatments for PXE: Targeting the Systemic and Local Drivers of Ectopic Calcification. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015041
BibTeX
@article{Jacobs2023,
author = {Jacobs, Ida Joely and Li, Qiaoli},
title = {Novel Treatments for PXE: Targeting the Systemic and Local Drivers of Ectopic Calcification},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242015041}
}
EUVIMED